Blood filtering with citrate for kidney injury in intensive care
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at using a blood thinner called citrate during continuous kidney dialysis (renal replacement therapy) in critically ill patients with acute kidney injury. It aims to see if this approach is safe and workable for patients whose bodies may not process citrate normally.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need kidney replacement therapy while in the intensive care unit (ICU).
- You must have a condition that makes it hard for your body to process citrate, such as high lactate levels (a sign of severe illness), a need for glucose infusions to prevent low blood sugar, or severe liver problems.
- You may have developed citrate toxicity from a previous treatment with this same method.
- You cannot be pregnant, allergic to citrate, or unwilling to give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares the usual dose of continuous dialysis with a lower dose to see if a lower dose is just as safe and effective for critically ill patients with sudden kidney failure.
This study tests whether a specific blood-thinning method using citrate works safely and effectively in critically ill patients whose kidneys have suddenly stopped working and need a special filtering machine. Researchers want to confirm that this approach prevents dangerous blood clots while keeping patients safe.
This study tests how safe a specific blood thinner called “citrate” is when used during continuous kidney dialysis (CRRT) for people with AKI or kidney failure. If you qualify, your care team will compare citrate safety against standard approaches to see if it’s tolerable and safe.
This trial compares two types of dialysis (hemodialysis and hemodiafiltration) to see which is better at removing waste from the blood in ICU patients with sudden kidney failure. It may help doctors choose the best treatment for you.
This trial looks at how a type of continuous kidney dialysis, called CRRT, works in very sick patients in the intensive care unit. It may help doctors learn more about how to best care for people who need this treatment.
This trial looks at different types of continuous kidney dialysis (CRRT) to see which best helps kidney recovery in ICU patients with sudden kidney injury. It also studies how the dose and timing of dialysis affect long-term kidney function.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.